Cent Gardes Conference: HIV Vaccines. Organized by Fondation Mérieux «Les Pensières» Fondation Mérieux Conference Center Veyrier du Lac - France

Similar documents
Cent Gardes Conference: HIV Vaccines. Organized by Fondation Mérieux Les Pensières Center for Global Health Veyrier du Lac - France

HIV Vaccine Conference

Demand side interventions to increase and sustain vaccination uptake

Vaccination ecosystem health check: achieving impact today and sustainability for tomorrow

Professor Andrew McMichael

Immunogens and Antigen Processing: Report from a Global HIV Vaccine Enterprise Working Group

Arboviruses: A Global Public Health Threat

HVTN Laboratory Program: Immunogenicity and Research Assays

S C I E N T I F I C P R O G R A M M E Last Update: 20/03/2013

Should There be Further Efficacy Testing of T-T cell Based Vaccines that do not Induce Broadly Neutralizing Antibodies?

From package to protection - how do we close global coverage gaps to optimise the impact of vaccination?

5 th Annual GABRIEL meeting 9-12 December, 2012 Les Pensières, Annecy, France

Global Challenges in Vaccine Acceptance Science and Programs

Correlates of enteric vaccine-induced protection

Lynn Morris. "Plan B"- bnabs for HIV prevention

2015 Towards an HIV Cure Symposium 18 & 19 July 2015 Hyatt Regency Hotel, Vancouver, Canada

IAS Towards an HIV Cure Symposium. Victoria University City Convention Center, Melbourne, Australia

Joint Meeting of the Working Groups on Surveillance (Laboratory & Epidemiology) 16 to 18 April 2018 Annecy, France AGENDA

FUNDERS UPDATE- BMGF. Third HIV Env Manufacturing Workshop Sponsored by DAIDS-NIAID-NIH and the HIV Global Vaccine Enterprise July 20-21, 2017

BEAT-HIV Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy

"Development and Clinical Progress. of DNA Vaccines" Program

CHARITY DINNER LINK FOR AIDES DEC PAVILLON CAMBON PARIS FRANCE

AGE DA. 8:00-8:30 Breakfast All. 8:30-8:40 Introductions All. 8:40-8:55 Mandate of the Enterprise Alan Bernstein

27-28 November, 2017 Paris, France Espace Saint-Martin

HIV cure: current status and implications for the future

Are we targeting the right HIV determinants?

Preclinical Animal Models for HIV Cure Research in Children: Scientific Knowledge Gaps

Proposal for a Workshop

Higher priming doses enhance HIV-specific humoral but not cellular. responses in a randomized, double-blind phase Ib clinical trial of

Communication of vaccine benefit beyond the infection prevented

SCIENTIFIC PROGRAM ANNECY ARTHROSCOPIC ARTHROPLASTY SHOULDER ACADEMY. 11 th to 13 th November CHAIRMAN: Dr Laurent LAFOSSE Annecy - France

Adolfo Garcia-Sastre, New York, USA

ESPACOMP SCIENTIFIC MEETING PROGRAM

HIV and Challenges of Vaccine Development

Asier Sáez-Cirión, PhD Unité de Régulation des Infections Rétrovirales Institut Pasteur, Paris, France

HIV: RV 144 prime boost HIV vaccine efficacy study

SCIENTIFIC PROGRAM ORAL PRESENTATIONS. Friday October, 26 th OPENING SESSION

Novel Vaccine Products for Planned Phase I Immunogenicity Studies in Infants

Crystal structure of the neutralizing antibody HK20 in complex with its gp41 antigen

EMERGING ISSUES IN THE HUMORAL IMMUNE RESPONSE TO HIV. (Summary of the recommendations from an Enterprise Working Group)

ESSO Advanced Course on Upper GI Robotic Surgery

PROVISIONAL SCIENTIFIC PROGRAMME AND TIMETABLE

Trial Objectives immunogenicity safety

Progress in HIV Vaccine Development Magdalena Sobieszczyk, MD, MPH. Division of Infectious Diseases Columbia University Medical Center

Epigenetic and Metabolic Regulation of Aging and Aging-Related Diseases

Dirk Heinz, Helmholtz Centre for Infection Research, Germany SESSION I: INDIVIDUALIZED MEDICINE TODAY AND TOMORROW

Residual Cancer. May 3-5, International Symposium. on Minimal. Le Corum. > Preliminary. Program MONTPELLIER, FRANCE

DST-NRF Centre of Excellence in HIV Prevention

LYON. FRANCE NOVEMBER / 2013 TRANSLATIONAL RESEARCH IN CHRONIC VIRAL HEPATITIS - BRIDGING BASIC SCIENCE AND CLINICAL RESEARCH

In pursuit of an HIV vaccine: an interview with Andrew McMichael

Christophe Mérieux Conference: New Trends in Tumor Virology

Dirk Heinz, Helmholtz Centre for Infection Research, Germany SESSION I: INDIVIDUALIZED MEDICINE TODAY AND TOMORROW

HIV Pathogenesis and Natural History. Peter W. Hunt, MD Associate Professor of Medicine University of California San Francisco

Itinerary for the Field School. Social Science Research Techniques for Post Conflict Areas October 2015

Identification and Characterization of CD4 T cells actively transcribing HIV RNA in Peripheral Blood

From Antibody to Vaccine a Tale of Structural Biology and Epitope Scaffolds

HIV: A DISCOVERY OPENING THE ROAD TO NOVEL SCIENTIFIC KNOWLEDGE AND GLOBAL HEALTH IMPROVEMENT

Spontaneous Control of Viral Replication during Primary HIV Infection: When Is HIV Controller Status Established?

HCC and the Hallmarks of Cancer: steps towards novel therapeutic strategies

Press conference abstracts Vaccine and Antibody Research Monday, 22 October 2018

squamous cell carcinoma of the head and neck (SCCHN)

Induction of Immunity to Human Immunodeficiency Virus Type-1 by Vaccination

Immune correlates of protection from congenital cytomegalovirus after primary infection in pregnancy

State of the ART: HIV Cure where are we now and. where are we going? Jintanat Ananworanich, MD, PhD MHRP

AIDSVaccine2010 Atlanta, Georgia Willy Bogers. NIH HIVRad Grant nr 5P01AI066287

Registration for INTEREST 2019 is now open!

Target audience. Chair. Xxx Xxx

EACS HIV Summer School PRELIMINARY PROGRAMME

Understanding HIV. Transmitted/Founder Viruses. Brandon Keele SAIC-Frederick National Cancer Institute

Development of a Recombinant Subunit Dengue Vaccine. Flavivirus Vaccination Fondation Mérieux December 8, 2010 Beth-Ann Coller

COMPLETE PRESS CONFERENCE SCHEDULE

Establishment and Targeting of the Viral Reservoir in Rhesus Monkeys

University Hospital of Zürich Auditorium Grosser Hörsaal B - OST Rämistrasse 100, 8091 Zürich Switzerland

1 st EUNAAPA Summer School on Physical Activity and Ageing

HIV/AIDS: vaccines and alternate strategies for treatment and prevention

Ethical Challenges in Clinical Research at Both Ends of Life

Antibody Dependent Cellular Cytotxic activity: Past and Future. Guido Ferrari, M.D. Duke University Medical Center

Antibody gene transfer for HIV immunoprophylaxis

The Towards an HIV Cure initiative would like to thank the following organizations for their generous support in 2015

Can HIV be cured? (how about long term Drug free remission?)

Primate models of SIV infection: Differenct susceptibility of African green monkeys and macaques to develop AIDS

Target audience. Chair. Xxx Xxx

Phase II clinical trial TEmAA. Didier Koumavi EKOUEVI, MD PhD (Principal Investigator)

Course in Cancer Metabolism

versus CD4. PoC - Messaging - Specificity and - Ethics sensitivity of HIV - Feedback from diagnostic tests demonstration projects

HIV Vaccines. Join Keystone Symposia for the 2016 conference on: March 20 24, 2016 Resort at Squaw Creek Olympic Valley, California USA

ESMO Symposium on Immuno-Oncology Programme book

GLOBAL INVESTMENT IN HIV CURE RESEARCH AND DEVELOPMENT IN 2017 AFTER YEARS OF RAPID GROWTH FUNDING INCREASES SLOW

LETTER TO PARTNERS 09

Pathogens Survival Strategies

July 5 & 6, 2018, Paris SCIENTIFIC PROGRAM

Spike Trimer RNA. dsdna

Infos:

NIAID Vaccine Research Center: A Mission to Prevent HIV Infection

Approaching a Cure Daniel R. Kuritzkes, MD

Safety of Paediatric CTs. A view of the PDCO

23 May 3 June Les Pensières Veyrier-du-Lac (French Alps) Application deadline: 15 November 2015

CROI 2016 Review: Immunology and Vaccines

SESSION 1: Epidemiology of IBI in the EU, an overview Chairman: Lucia Pastore Celentano (ECDC)

1:10 1:30 Opening Lecture: Vice Rector Research and Innovation: Prof. Eugene Cloete, Stellenbosch University. (South Africa)

Transcription:

Cent Gardes Conference: HIV Vaccines Organized by Fondation Mérieux «Les Pensières» Fondation Mérieux Conference Center Veyrier du Lac - October 6 to 8, 2017

Steering Committee Members Françoise Barré-Sinoussi François Dabis Jean-François Delfraissy Yves Levy Benoît Miribel Giuseppe Pantaleo Institutions 2008 Nobel Prize in Medicine and Physiology ANRS, Recherche Nord & Sud Sida-hiv Hépatites Comité consultatif national d'éthique CEA/INSERM/Université Paris Sud INSERM Fondation Mérieux Centre Hospitalier Universitaire Vaudois Switzerland Scientific Advisory Board Members Marcus Altfeld Constance Delaugerre Serge Eholié Gunilla Karlsson Hedestam Michel Nussenzweig Giuseppe Pantaleo Gabriella Scarlatti Olivier Schwartz Georgia Tomaras Carolyn Williamson Linqi Zhang Institutions HPI Hamburg Germany CHU Saint-Louis AP-HP University Félix Houphouet-Boigny Yvory Coast Karolinska Institutet Sweden CEA/INSERM/Université Paris Sud The Rockefeller University USA Centre Hospitalier Universitaire Vaudois Switzerland San Raffaele Scientific Institute Italia Institut Pasteur Duke University Medical Center USA University of Cape Town South Africa Tsinghua University China

Organizing Committee Members Guiseppe Pantaleo Cindy Grasso Valentina Picot Institutions CEA/INSERM/Université Paris Sud Centre Hospitalier Universitaire Vaudois Switzerland Fondation Mérieux Fondation Mérieux

Scientific Programme Friday, October 6 th 2017 13h00-13h30 Registration 13h30-14h00 Welcome addresses Benoît Miribel Jean-François Delfraissy François Dabis Giuseppe Pantaleo Session 1 Regulation of induction of protective immune responses in natural infection and following vaccination Chair: Andrew McMichael 14h00-14h25 Presentation 1 Antonio Lanzavecchia 14h25-14h50 B Cell Activation Induces a Switch from Canonical to non-canonical Autophagy that Shapes B Cell Fate Facundo Batista Session 2 Update on HIV prevention: what are we learning from the clinic (immune correlates, vaccine, other interventions (PrEp) Chair: Robin Shattock 14h50-15h15 T cell responses and vaccine protection in prophylactic vaccines Julie McElrath 15h15-15h40 Presentation 2 Georgia Tomaras 15h40-16h05 Presentation 3 Larry Corey 16h05-16h30 Presentation 4 Sheena McCormack 16h30-16h55 Control of HIV infection by T cells Persephone Borrow 16h55-17h20 19h00 Dinner

Saturday, October 7th 2017 Role of antibodies in HIV Prevention and Therapy 8h30-9h15 Keynote lecture: B cell biology and germinal center formation Michel Nussenzweig Session 3 Advances in the development of bnabs and non-bnabs (antigen design and preclinical models ) Chair: John Moore & Carolyn Williamson 9h15-9h40 Presentation 1 Anthony Moody 9h40-10h05 Presentation 2 William Schief 10h05-10h30 10h30-11h00 11h00-11h25 11h25-11h50 11h50-12h15 Native-like HIV-1 envelope trimers that activate germline precursors of broadly neutralizing antibody precursors in vivo Coffee Break Structure-Based Elicitation of Fusion Peptide-Directed Antibodies that Neutralize Diverse Strains of HIV Structure-based design of improved antibodies against HIV Recapitulation of HIV-1 Envelope-Antibody Coevolution in Rhesus Macaques Leading to Neutralization Breadth Rogier Sanders Peter Kwong Pamela Bjorkman George Shaw 12h15-12h40 Presentation 7 Leo Stamatatos 12h40-14h00 Lunch

Session 4 Advances in the development of bnabs and non-bnabs (antigen design and preclinical models ) Chair: Susan Zolla-Pazner 14h00-14h25 Presentation 1 Dennis Burton 14h25-14h50 Presentation 2 Barton Haynes 14h50-15h15 15h15-15h40 15h40-16h10 16h10-16h40 HIV-1 Envelope Modifications that Permit Neutralization by Germline and Early Intermediates of CD4bs Broadly Neutralizing Antibodies Targeting productively and latently infected cells with antibodies Coffee Break David Montefiori Olivier Schwartz Session 5 bnabs and non-bnabs in prevention and therapy Chair: Linqi Zhang 16h40-17h05 17h05-17h30 17h30-17h55 Clinical Evaluation of anti-hiv Broadly Neutralizing Antibodies Antibody-mediated prevention of HIV-1 Infection Using anti-hiv 1 bnabs for Treatment and Prevention Marina Caskey John Mascola Malcom Martin 17h55-18h20 Presentation 4 Carolyn Williamson 18h20-18h50 19h00 Dinner

Sunday, October 8 th 2017 Mechanisms of transmission and mucosal immunity Session 6 Mechanisms of transmission and mucosal immunity Chair: Jake Estes 8h30-8h55 Presentation 1 Hugo Mouquet 8h55-9h20 Presentation 2 Robin Shattock 9h20-9h45 9h45-10h15 10h15-10h45 Early viral replication and dissemination dynamics following vaginal infection of a molecularly tagged SIV in rhesus macaques Coffee Break Brandon F. Keele HIV Functional Cure Session 7 HIV persistence and cell reservoir (molecular mechanisms, cell reservoir in blood and tissue cell populations) Chair: Olivier Lambotte and Jean-Daniel Lelièvre 10h45-11h10 Presentation 1 Jake Estes 11h10-11h35 Presentation 2 Warner Greene 11h35-12h00 Presentation 3 Giuseppe Pantaleo 12h00-13h30 Lunch 13h30-13h55 Presentation 4 Monsef Benkirane 13h55-14h20 Presentation 5 Thumbi Ndungu 14h20-14h50

Session 8 Immune-based interventions Chair: François Dabis 14h50-15h15 Immune-based interventions for HIV cure: lessons from NHP models Guido Silvestri 15h15-15h40 Presentation 2 Asier Saez-Cirion 15h40-16h05 Presentation 3 Yves Levy 16h05-16h35 16h35-17h00 17h00 Conclusions End of Meeting Giuseppe Pantaleo